The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy

por Lekakis, Lazaros J., Moskowitz, Craig H.
Publicado 2019

A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma

por Kuker, Russ A., Lehmkuhl, David, Kwon, Deukwoo, Zhao, Weizhao, Lossos, Izidore S., Moskowitz, Craig H., Alderuccio, Juan Pablo, Yang, Fei
Publicado 2022

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013

por Ribrag, Vincent, Armand, Phillippe, Kuruvilla, John, Michot, Jean-Marie, Moskowitz, Craig H, Marinello, Patricia, Snyder, Ellen, Balakumaran, Arun, Shipp, Margaret A, Zinzani, Pier Luigi
Publicado 2015

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087

por Chen, Robert, Armand, Phillippe, Fanale, Michelle A, Ribrag, Vincent, Zinzani, Pier Luigi, Ricart, Alejandro D, Thompson, Seth, Balakumaran, Arun, Molin, Daniel, Shipp, Margaret A, Moskowitz, Craig H
Publicado 2015

Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma

por Driessen, Julia, Zwezerijnen, Gerben J. C., Schöder, Heiko, Kersten, Marie José, Moskowitz, Alison J., Moskowitz, Craig H., Eertink, Jakoba J., Heymans, Martijn W., Boellaard, Ronald, Zijlstra, Josée M.
Publicado 2023

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse

por Kumar, Anita, Sha, Fushen, Toure, Ahmed, Dogan, Ahmet, Ni, Andy, Batlevi, Connie L., Palomba, Maria Lia M., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Moskowitz, Alison, Hamlin, Paul, Moskowitz, Craig H., Matasar, Matthew J., Zelenetz, Andrew D., Younes, Anas
Publicado 2019

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

por Armand, Philippe, Zinzani, Pier Luigi, Lee, Hun Ju, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Herrera, Alex F., Lin, Jianxin, Kim, Eunhee, Chakraborty, Samhita, Marinello, Patricia, Moskowitz, Craig H.
Publicado 2023

P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Ind...

por Driessen, Julia, De Wit, Fer, Herrera, Alex F., Zinzani, Pier Luigi, Lacasce, Ann S., Cole, Peter D., Moskowitz, Craig H., Sanz, Ramón. García, Fuchs, Michael, Müller, Horst, Borchmann, Peter, Santoro, Armando, Schöder, Heiko, Zijlstra, Josée. M., Hutten, Barbara A., Moskowitz, Alison J., Kersten, Marie José
Publicado 2022

P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untre...

por Radford, John, Adedayo, Toyin, Ardavan, Arzhang, Barrington, Sally F., Berkahn, Leanne, Chauvie, Stephane, Clifton-Hadley, Laura, Collins, Graham P., Crump, Michael, Cutter, David, Edwards, Darren, Hutchings, Martin, Illidge, Tim, Kirkwood, Amy A., Linton, Kim, Moskowitz, Craig H., Patrick, Pip, Phillips, Beth, Shepherd, Lois, Tonino, Sanne, Trotman, Judith, Williams, Joanna, Doo, Nicole Wong
Publicado 2022

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting

por Zheng, Serena, Gupta, Kanika, Goyal, Piyush, Nakajima, Reiko, Michaud, Laure, Batlevi, Connie Lee, Hamlin, Paul A., Horwitz, Steven, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Palomba, M. Lia, Straus, David J., Von Keudell, Gottfried, Falchi, Lorenzo, Yahalom, Joachim, Zelenetz, Andrew D., Younes, Anas, Salles, Gilles, Schöder, Heiko, Joffe, Erel
Publicado 2023

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

por Batlevi, Connie L., Sha, Fushen, Alperovich, Anna, Ni, Ai, Smith, Katy, Ying, Zhitao, Soumerai, Jacob D., Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Owens, Colette, Palomba, Lia M., Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas
Publicado 2020

T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory...

por Moskowitz, Alison J., Shah, Gunjan, Schöder, Heiko, Ganesan, Nivetha, Hancock, Helen, Davey, Theresa, Perez, Leslie, Sohail, Samia, Santarosa, Alayna, Capadona, Charisse, Munayirji, Brittney, Kumar, Anita, Lahoud, Oscar, Batlevi, Connie, Hamlin, Paul, Straus, David J., Owens, Colette, Caron, Philip, Intlekofer, Andrew, Hamilton, Audrey, Horwitz, Steven, Falchi, Lorenzo, Johnson, William, Palomba, Lia, Noy, Ariela, Matasar, Matthew, Pongas, Georgios, Salles, Gilles, Vardhana, Santosha, Sanin, Beatriz Wills, Yahalom, Joachim, Dogan, Ahmet, Zelenetz, Andrew, Moskowitz, Craig H.
Publicado 2022

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay

por Intlekofer, Andrew M., Joffe, Erel, Batlevi, Connie L., Hilden, Patrick, He, Jie, Seshan, Venkatraman E., Zelenetz, Andrew D., Palomba, M. Lia, Moskowitz, Craig H., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Gerecitano, John F., Moskowitz, Alison, Hamlin, Paul, Matasar, Matthew J, Kumar, Anita, van den Brink, Marcel R., Knapp, Kristina M., Pichardo, Janine D., Nahas, Michelle K., Trabucco, Sally E., Mughal, Tariq, Copeland, Amanda R., Papaemmanuil, Elli, Moarii, Mathai, Levine, Ross L., Dogan, Ahmet, Miller, Vincent A., Younes, Anas
Publicado 2018